Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Life Time Group Holdings
LTH
$10.1B
| $135K | ﹤0.01% |
11,290
+9,507
| +533% | +$109K |
|
3927
Timberland Bancorp
TSBK
$348M
| $134K | ﹤0.01% |
3,928
+3,490
| +797% | +$112K |
|
3928
Evolution Petroleum
EPM
$132M
| $134K | ﹤0.01% |
17,753
+15,367
| +644% | +$116K |
|
3929
Eldorado Gold
EGO
$7.87B
| $134K | ﹤0.01% |
16,000
-25,044
| -61% | -$178K |
|
3930
VSE Corp
VSEC
$5.45B
| $133K | ﹤0.01% |
2,847
+2,373
| +501% | +$108K |
|
|
ALBO
3931
DELISTED
Albireo Pharma Inc
ALBO
| $133K | ﹤0.01% |
6,163
+4,160
| +208% | +$87.9K |
|
|
PTVE
3932
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $132K | ﹤0.01% |
11,607
+9,251
| +393% | +$101K |
|
3933
Costamare
CMRE
$1.88B
| $132K | ﹤0.01% |
14,186
+11,946
| +533% | +$112K |
|
|
BLNG
3934
DELISTED
Belong Acquisition Corp. Class A Common Stock
BLNG
| $132K | ﹤0.01% |
13,299
| – | – |
|
3935
Nuvation Bio
NUVB
$2.2B
| $131K | ﹤0.01% |
68,462
+11,909
| +21% | +$24.1K |
|
3936
Maui Land & Pineapple Co
MLP
$344M
| $131K | ﹤0.01% |
13,932
-605
| -4% | -$5.43K |
|
|
CMAX
3937
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $131K | ﹤0.01% |
1,198
+65
| +6% | +$9.72K |
|
3938
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.31B
| $131K | ﹤0.01% |
1,500
+500
| +50% | +$44.8K |
|
3939
Cimpress
CMPR
$2.39B
| $131K | ﹤0.01% |
4,738
+3,990
| +533% | +$103K |
|
3940
Senseonics Holdings Inc
SENS
$263M
| $131K | ﹤0.01% |
6,349
+5,378
| +554% | +$124K |
|
3941
Lightwave Logic
LWLG
$995M
| $131K | ﹤0.01% |
30,334
+25,595
| +540% | +$182K |
|
3942
Vaalco Energy
EGY
$570M
| $130K | ﹤0.01% |
28,533
+26,046
| +1,047% | +$131K |
|
|
MAG
3943
DELISTED
MAG Silver
MAG
| $130K | ﹤0.01% |
8,323
-58,817
| -88% | -$856K |
|
|
ORGN
3944
DELISTED
Origin Materials
ORGN
| $130K | ﹤0.01% |
940
-1,656
| -64% | -$264K |
|
3945
ALX Oncology
ALXO
$261M
| $130K | ﹤0.01% |
11,528
+4,851
| +73% | +$54.5K |
|
3946
SiNtx Technologies
SINT
$10.8M
| $130K | ﹤0.01% |
+67
| New | +$161K |
|
3947
Argan
AGX
$8B
| $130K | ﹤0.01% |
3,517
+2,949
| +519% | +$104K |
|
3948
UroGen Pharma
URGN
$1.86B
| $129K | ﹤0.01% |
14,599
+10,817
| +286% | +$102K |
|
3949
Artesian Resources
ARTNA
$355M
| $129K | ﹤0.01% |
2,207
+1,714
| +348% | +$90.2K |
|
|
REV
3950
PUT
DELISTED
Revlon, Inc.
REV
| $129K | ﹤0.01% |
+300,000
| New | +$1.33M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.